Palatin files to sell 17.32M shares of common stock, warrants
A.G.P. is lead placement agent. Laidlaw & Company is co-placement agent. Don't Miss Our End of Quarter Offers: Discover the latest stocks ...
Palatin says BMT-801 Phase 2 obesity study met primary endpoint
Technologies announced that its BMT-801 Phase 2 obesity co-administration study met its primary endpoint and was highly ...